DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

InterContinental San Francisco

2018年11月05日 (月) 午前 7:00 - 2018年11月06日 (火) 午後 3:00

888 Howard Street, San Francisco, CA 94103

Real World Evidence Conference

This conference has reached maximum capacity.

Session 7: The Power of Harnessing RWD from Wearables

Session Chair(s)

Gabriela  Lavezzari, PhD, MBA

Gabriela Lavezzari, PhD, MBA

Senior Director, US R&D Policy and Scientific Affairs

GlaxoSmithKline, United States

In today’s healthcare system, we have greater access to technology with infinite amount of data literally at our fingertips. Wearable technology has introduced a new way to collect additional patient information by providing access to the real-world patient experience. This session will investigate case studies of current efforts aimed at using wearable technologies for drug development and regulatory decision-making along with lesson learned from the medical device community on medical devices that won new indications based on RWE.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify areas where medical devices have successfully used RWE for regulatory decision-making
  • Discuss case studies that showcase advances in the use of wearable technologies
  • Identify areas where immediate regulatory policies are needed to streamline the use of wearable technologies for regulatory decision-making in drug development

Speaker(s)

Pierre-Alexandre  Fournier, MSc

The Power of Harnessing RWD from Wearables

Pierre-Alexandre Fournier, MSc

Hexoskin, Canada

Co-Founder and CEO

George  Savage, MD

The Power of Harnessing RWD from Wearables

George Savage, MD

Proteus Digital Health, United States

Co-founder and Chief Medical Officer

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。